Showing 681 - 700 results of 806 for search '"Perioperative"', query time: 0.06s Refine Results
  1. 681
  2. 682
  3. 683

    Utilizing vaginal natural orifice to facilitate bowel manipulation during totally intracorporeal ileal conduit construction: a retrospective cohort study by Kaipeng Jia, Shiwang Huang, Zhun Wang, Yuda Lin, Yiduo Bai, Chong Shen, Zhe Zhang, Zhouliang Wu, Yunkai Qie, Hailong Hu

    Published 2025-12-01
    “…Objective To explore the feasibility and efficacy of the modified technique of totally intracorporeal ileal conduit (IC) construction via vaginal approach following robot-assisted radical cystectomy (RARC) in females.Methods By comparing the perioperative outcomes of the modified technique with extracorporeal urinary diversion (ECUD), 31 females treated for bladder cancer with RARC and IC from May 2020 to December 2023 were retrospectively analyzed and divided into two groups: the ECUD group (10 patients) and the modified intracorporeal urinary diversion (MICUD group) (21 patients). …”
    Get full text
    Article
  4. 684

    Renal Transplantation in Secondary Amyloidosis Associated with Tuberculosis by Vivek B. Kute, Aruna V. Vanikar, Himanshu V. Patel, Manoj R. Gumber, Pankaj R. Shah, Pranjal R. Modi, Hargovind L. Trivedi

    Published 2013-01-01
    “…She had immediate good graft function without any perioperative complications (cardiovascular, infections, rejection and delayed graft function). …”
    Get full text
    Article
  5. 685

    Flurbiprofen Axetil Enhances Analgesic Effects of Sufentanil and Attenuates Postoperative Emergence Agitation and Systemic Proinflammation in Patients Undergoing Tangential Excisio... by Wujun Geng, Wandong Hong, Junlu Wang, Qinxue Dai, Yunchang Mo, Kejian Shi, Jiehao Sun, Jinling Qin, Mei Li, Hongli Tang

    Published 2015-01-01
    “…Our present study tested whether flurbiprofen axetil could reduce perioperative sufentanil consumption and provide postoperative analgesia with decrease in emergency agitation and systemic proinflammatory cytokines release. …”
    Get full text
    Article
  6. 686

    Risk Factors For Progression From Biochemical Leak to Clinically Relevant Postoperative Pancreatic Fistula After Pancreaticoduodenectomy. The Key of the Lock: Prognostic Nutritiona... by Mehmet Can Aydin, Oguzhan Ozsay, Kagan Karabulut, Recep Bircan, Fatih Atalay, Mehmet Batuhan Ors

    Published 2025-02-01
    “…The groups were compared in terms of preoperative data, perioperative findings, and postoperative results. Risk factors for progression from BL to CR-POPF were analyzed. …”
    Get full text
    Article
  7. 687
  8. 688

    Comparison of robotic-assisted and laparoscopic partial nephrectomy based on the PADUA score and the predictive value of the PADUA score and the Mayo Adhesive Probability score for... by Shuo Liu, Bowen Zhang, Bowen Weng, Xiangqiang Liu, Sichuan Hou

    Published 2024-12-01
    “…Abstract Purpose This study compared perioperative outcomes of robot-assisted partial nephrectomy (RAPN) and laparoscopic partial nephrectomy (LPN) through the PADUA score as well as assessed the predictive value of the PADUA score and the Mayo Adhesive Probability (MAP) score for postoperative complications. …”
    Get full text
    Article
  9. 689

    Clinical impact of the prognostic nutritional index and skeletal muscle index for the incompletion of adjuvant chemotherapy for pancreatic cancer by Hiromitsu Maehira, Haruki Mori, Nobuhito Nitta, Takeru Maekawa, Yusuke Nishina, Hajime Ishikawa, Katsushi Takebayashi, Sachiko Kaida, Toru Miyake, Masaji Tani

    Published 2025-02-01
    “…The patients were assigned to two groups according to their completion or incompletion of adjuvant chemotherapy. We compared the perioperative skeletal muscle mass index (SMI) and nutritional status using prognostic nutritional index (PNI) between the two groups. …”
    Get full text
    Article
  10. 690
  11. 691

    Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience by Beatrice Manfredini, Carmelina Cristina Zirafa, Alessandro Stefani, Gaetano Romano, Greta Alì, Riccardo Morganti, Ilaria Ceccarelli, Federico Davini, Pier Luigi Filosso, Franca Melfi

    Published 2025-01-01
    “…Information regarding perioperative outcomes and lymphadenectomy details was collected and analyzed, and their impact on OS, CSS, and DFS was assessed. …”
    Get full text
    Article
  12. 692
  13. 693

    ASA Class Is a Stronger Predictor of Early Revision Risk Following Primary Total Knee Arthroplasty than BMI by Christopher J. Wall, MBBS, BMedSc, FRACS, FAOrthA, Richard N. de Steiger, MBBS, PhD, DipBiomech, FRACS, FAOrthA, Christopher J. Vertullo, MBBS, PhD, FRACS, FAOrthA, Dylan Harries, BSc(Hons), MBiostat, PhD, Srinivas Kondalsamy-Chennakesavan, MBBS, MPH, FRSPH

    Published 2025-03-01
    “…Employing a BMI threshold in isolation when assessing fitness for TKA may be inappropriate, and surgeons should give greater weight to the other medical comorbidities and general perioperative fitness of the patient. Patients with poorly controlled comorbidities should be referred for medical optimization prior to TKA. …”
    Get full text
    Article
  14. 694

    From Guidelines to Action: Tackling Risk Factors for Surgical Site Infections by Caterina Elisabetta Rizzo, Roberto Venuto, Paola Tripodi, Linda Bartucciotto, Elvira Ventura Spagnolo, Antonio Nirta, Giovanni Genovese, Isabella La Spina, Sabrina Sortino, Alessandro Nicita, Francesco Loddo, Bruno Romeo, Raffaele Squeri, Cristina Genovese

    Published 2025-01-01
    “…The aim of this study is to investigate potential risk factors that may adversely affect the development of SSIs, as well as to assess the appropriateness and adherence to perioperative antibiotic prophylaxis. <b>Methods:</b> This observational study was conducted from October 2023 to October 2024 at the University Hospital of Messina, Italy, a hospital performing both thoracic and vascular surgery. …”
    Get full text
    Article
  15. 695

    Randomised controlled trial comparing intraoperative cell salvage and autotransfusion with standard care in the treatment of hip fractures: a protocol for the WHITE 9 study by Mike Murphy, Nicholas Parsons, James Mason, Juul Achten, Duncan Appelbe, Edward Dickenson, Damian Griffin, Katy Mironov, Matthew Wyse, Amrita Athwal, Xavier Luke Griffin, Heather O'Connor

    Published 2022-06-01
    “…Approximately 30% of patients require a donor blood transfusion in the perioperative period. Donor blood transfusions are associated with increased rates of infections, allergic reactions and longer lengths of stay. …”
    Get full text
    Article
  16. 696

    Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma by Yuan Tian, Qun Zhao, Yong Li, Liqiao Fan, Zhidong Zhang, Xuefeng Zhao, Bibo Tan, Dong Wang, Peigang Yang

    Published 2021-01-01
    “…A total of 300 patients aged 20-60 years with resectable gastric or gastroesophageal junction adenocarcinoma who were evaluated with cT3/4Nany were randomly assigned into 3 groups: DOX group (n=100, treated with neoadjuvant DOX plus adjuvant XELOX), XELOX group (n=100, treated with perioperative XELOX), and surgery group (n=100, treated with adjuvant XELOX). …”
    Get full text
    Article
  17. 697

    Post‐operative incidence of lymphedema after RARP with or without extended pelvic lymph node dissection in a cohort study by Andries Clinckaert, Laura Ysenbaardt, Annabel Bijnens, Charlotte Van Calster, Inge Geraerts, Steven Joniau, Nele Devoogdt, Luc Bijnens, Wouter Everaerts

    Published 2025-01-01
    “…Structured electronic case report forms (eCRFs) integrated into the electronic health record system were used to document intraoperative, perioperative and postoperative data. The primary endpoint was the incidence of lymphedema. …”
    Get full text
    Article
  18. 698
  19. 699

    Implementation of a Cost and Variation Reduction Program for Hemostasis Products at a Large Academic Medical Center: A Multi-Stakeholder Perspective by Shah T, Brethauer S, Danker III WA, Doshi I, O'Hara M, Silber A, Vasileff WK

    Published 2025-01-01
    “…Thus, we sought to evaluate hospital stakeholder satisfaction with conversion to a sole supplier for hemostasis products, in addition to economic and clinical impacts, to help develop best practices for implementation.Methods: This cross-sectional study assessed satisfaction with converting to a sole supplier for hemostasis products at a large US academic medical center using qualitative interviews and quantitative surveys with clinical and non-clinical stakeholders, on the decision-making process, conversion, and vendor-supported hemostasis optimization program (HOP) post-implementation (February 2022–May 2022). Perioperative hemorrhage events, adjunctive hemostat utilization, and total annual hospital expenditure on hemostatic products were also evaluated pre- and post-conversion (2020– 2022) to identify impacts on clinical and economic outcomes.Findings: Ten hospital stakeholders completed qualitative interviews (n = 7 surgeons, n = 2 surgical technicians, n = 1 administrator) and 22 completed quantitative surveys (n = 6 surgeons, n = 5 surgical technicians, n = 11 nurses). …”
    Get full text
    Article
  20. 700